

Not only were there thousands of angry comments on the internet, but Colvin says he received death threats and hate mail. He even had someone bang on his door in the middle of the night. The Times reports he “expressed remorse” about his scheme saying he “didn’t realize the gravity of the coronavirus outbreak or the severe shortage of sanitizer and wipes.” I personally think that’s a bit disingenuous as his entire buy low/sell high scheme was predicated on the idea that folks would pay the inflated prices due to unavailability of hand sanitizer and wipes. “I’ve been buying and selling things for 10 years now,” he told the Times. “There’s been hot product after hot product. But the thing is, there’s always another one on the shelf. When we did this trip, I had no idea that these stores wouldn’t be able to get replenished.” “It was never my intention to keep necessary medical supplies out of the hands of people who needed them,” he said, crying. “That’s not who I am as a person. And all I’ve been told for the last 48 hours is how much of that person I am.” Not to be harsh, but I would guess Colvin is most probably exactly THAT person. (source: New York Times)
Price Gouging CEO Announces Reduction In Drug Price After Hiking Price Over 5,000% Overnight
Current CEO of pharma company Turing (and professional asshole) Martin Shkreli outraged the medical world this week when he raised the price of Daraprim, a drug used to treat AIDS and cancer patients fighting life-threatening parasitic infections, by over 5,000%, from $13.50 to $750 a tablet literally overnight.
According to reports the pills cost about $1 to make.
The internet went wild over the news, with many calling Shkreli the “most-hated man in America.”
Now, the 32-year-old ex-hedge-funder has announced he will lower the price of Daraprim. How much remains to be seen.
From The Gaily Grind:
“We’ve agreed to lower the price of Daraprim to a price that is more affordable,” Shkreli said on ABC World News Tonight. He did not say what the new “affordable” price would be.
“Yes, it is absolutely a reaction,” Shkreli told NBC News. “There were mistakes made with respect to helping people understand why we took this action. I think that it makes sense to lower the price in response to the anger that was felt by people.”
He continued: “It’s very easy to see a large drug price increase and say ‘Gosh, those people must be gouging.’ But when you find out that the company is not really making any money, what does that mean?”
“I think in the society we live in today it’s easy to want to villainize people,” he said. “Obviously, we’re in an election cycle where this is very, very tough topic for people and it’s very sensitive. And I understand the outrage.”
“We’ll know in several weeks how profitable the drug is, if it at all,” he said. “It may turn out that’s it not even profitable at all, even at this price.”
Hedge Fund Guy Buys AIDS Drug Company, Jacks Price From $13.50 Per Pill To $750
![]() |
| Martin Shkreli |
Former hedge fund manager turned pharmaceutical businessman, 32 year old Martin Shkreli, recently purchased the rights to a 62-year-old drug, Daraprim, used for treating life-threatening parasitic infections like AIDS and cancer patients experience.
Shkreli promptly raised the price overnight from $13.50 per tablet to a whopping $750.
That’s a 5,500 percent increase for the exact same pill.
From Raw Story:
Daraprim is used for treating toxoplasmosis — an opportunistic parasitic infection that can cause serious or even life-threatening problems in babies and for people with compromised immune systems like AIDS patients and certain cancer patients — that sold for slightly over $1 a tablet several years ago.
“This isn’t the greedy drug company trying to gouge patients, it is us trying to stay in business,” Shkreli explained, saying that many patients use the drug for far less than a year and that the new price is similar to other drugs used for rare diseases.
Shrkeli also defended his small pharmaceutical company saying, “It really doesn’t make sense to get any criticism for this.”
Yeah, yeah, yeah, I know – you buy a company, you get to charge whatever you want for the product.
But this is just GROSS.